کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3235217 | 1205444 | 2013 | 5 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Newer anti-hyperglycemic agents in type 2 diabetes mellitus – Expanding the horizon Newer anti-hyperglycemic agents in type 2 diabetes mellitus – Expanding the horizon](/preview/png/3235217.png)
Diabetes mellitus is a common, chronic and progressive disease resulting in micro and macrovascular complications. Many classes of drugs are available for treatment but still the search for newer anti-hyperglycemic agents continues to combat significant adverse effect profile, loss of efficacy, progressive nature of disease and improve patient compliance. New emerging therapies in pipeline include drugs targeting various pathophysiologic mechanisms like incretin based therapies, sodium glucose co-transporter inhibitors, glucokinase inhibitors, 11β hydroxy steroid dehydrogenase inhibitors, drugs modulating fatty acid metabolism, selective PPARγ receptor modulators and anti inflammatory agents. Aim of this review is to describe the emerging therapies for diabetes mellitus.
Journal: Apollo Medicine - Volume 10, Issue 2, June 2013, Pages 108–112